Jinhua Zhang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

MyD88 orchestrates fatty acid metabolism in tumor-associated macrophages and non-alcoholic fatty liver disease-related hepatocarcinogenesis.

MyD88 orchestrates fatty acid metabolism in tumor-associated macrophages and non-alcoholic fatty liver disease-related hepatocarcinogenesis.

Journal: Frontiers in immunology

Published: March 07, 2025

Comprehensive wound healing using ETN@Fe7S8 complex by positively regulating multiple programmed phases.

Comprehensive wound healing using ETN@Fe7S8 complex by positively regulating multiple programmed phases.

Journal: Journal of nanobiotechnology

Published: January 10, 2025

Lypd6b depletion promotes CD8+ T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer.

Lypd6b depletion promotes CD8+ T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer.

Journal: Nature communications

Published: September 07, 2024

New insights into T cell metabolism in liver cancer: from mechanism to therapy.

New insights into T cell metabolism in liver cancer: from mechanism to therapy.

Journal: Cell death discovery

Published: July 08, 2024

Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization.

Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization.

Journal: Cell death & disease

Published: May 31, 2024

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8+- T cell-mediated anti-tumor immunity.

Journal: Theranostics

Published: April 12, 2024

MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.

MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.

Journal: Cell communication and signaling : CCS

Published: October 09, 2023

The Immune Regulatory Role of Adenosine in the Tumor Microenvironment.

The Immune Regulatory Role of Adenosine in the Tumor Microenvironment.

Journal: International journal of molecular sciences

Published: September 06, 2023

Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway.

Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway.

Journal: International journal of molecular sciences

Published: July 16, 2022

MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.

MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization.

Journal: Cell death & disease

Published: January 18, 2022

MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway.

MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: October 29, 2021

MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs.

MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs.

Journal: International journal of molecular sciences

Published: October 13, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026